Kate Rosenbluth is a Founder, Member of the Board of Directors, and Chief Scientific Officer at Cala Health. She has previously served as Chief Executive Officer and raised three rounds of financing totaling over $80M. She is an engineer and neuroscientist, and has worked on cutting-edge neurotherapies at Stanford Biodesign, UCSF Neurosurgery, Brainlab, Autonomic Technologies and Genentech.

Doug Biehn previously served as the Executive Vice President of Marketing responsible for leading the growth strategy for iRhythm Technologies, one of the fastest growing digital health companies and also originated from the Stanford BioDesign program. He has also served as the Chief Operating Officer of AliveCor, Inc., a pioneer in AI enabled ECG detection ranked by Fast Company as one of the most innovative healthcare companies in 2017 and Chief Marketing Officer at Blue Shield of California where he helped achieve the fastest growing Blue Plan nationwide. Doug has a B.S. in Business Administration & Marketing from San Francisco State University and an M.B.A. from the University of San Francisco. Doug is a Board Advisor for a number of early stage digital health companies as well as volunteers as a Mentor for the Stanford Graduate School of Business Lean Launchpad program.

Deanna Harshbarger has spent 16 years in the medical device industry leading global upstream, downstream and clinical marketing teams in various positions at Medtronic, Boston Scientific, and Johnson & Johnson. She focused on building innovative pipelines and new franchises. Prior to her career in healthcare, Deanna spent time as a researcher and engineer in various industries. Deanna holds an MBA from the Kellogg School of Management at Northwestern University and a BS in Chemical Engineering from Case Western Reserve University.

Steve Higa has held numerous manufacturing, operational, and engineering roles in Silicon Valley. Prior to joining Cala Health, Steve worked as VP, Manufacturing for miraDry and held a VP, Operations role for Zoll Circulation. Steve holds an M.S. in Electrical Engineering from Santa Clara University. Outside of work, he enjoys golfing, watching basketball (Go Warriors!), and visiting Disneyland with his family.

Greg has 20 years of experience in product strategy, design, and engineering for companies and clients of all sizes focused in medical, utility, and consumer electronics. A mechanical engineer by training, Greg cofounded Guide Medical Ventures in 2011, managing strategic vision and technology for a portfolio of 6 start-ups in the medical device space. Prior to joining Cala Health, Greg led engineering at Mindtribe, a boutique hardware development consultancy acquired by Accenture. Greg started his career at Medtronic as a mechanical design engineer in neurological leads and honed his engineering leadership at Intelect Medical (acquired by Boston Scientific), Enpath Medical and EnteroMedics

Bobby Thomas has over two decades of experience in customer focused product innovation and has lead world-class engineering teams at companies like Intuitive Surgical, Blue Shield of California, Edifecs Inc, Kaiser and Navigating Cancer. A seasoned healthcare executive, Bobby has served in a variety of roles throughout his extensive career from startups to leading large scale enterprise transformation. He holds a Bachelor of Science in Computer Engineering. Outside of work, when not hacking away on open-source software, Bobby enjoys hiking and reading.

Jeron Evans joins Cala Health after previously serving as Vice President and Global Head of the Psoriasis Franchise at UCB BioPharma where he was responsible for building and leading the US dermatology business including sales, marketing and medical teams.  He then went on to lead a global commercial team managing a portfolio of dermatology assets.

Prior to UCB, Jeron served as Senior Vice President of Commercial Operations at Dermira, Inc., a fully integrated specialty pharmaceutical company.  Jeron was the first commercial employee at Dermira and worked across all commercial functions.  Dermira was acquired by Lilly in a transaction greater than $1B.

Jeron holds a Bachelor Science degree in Psychology from Vanderbilt University and an MBA from Everest University. 

Bernie is a senior medical device attorney with prior experience at GE, IBM, Johnson & Johnson, Miramar Labs and Earlens Corporation.  He joined Cala Health as the General Counsel.  Cala Health makes the Cala Trio, the first non-invasive targeted therapy that reduces hand tremors for adults living with Essential Tremor (ET). Prescription therapy is a simple, wrist-worn device that is calibrated to treat a patient’s unique tremor symptoms. When activated, Cala Trio gently stimulates the nerves in the wrist to disrupt the tremulous activity in the brain, without the need for invasive brain surgery or medication.